Skip to main content

CaLycia Bioscience

Salt Lake City, United States

CaLycia Bioscience is a biotechnology startup that develops myeloid-based cell therapy for treating tumors such as glioblastoma.

$400K raised
Jan 2026
Pre-Seed

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about CaLycia Bioscience

How much funding has CaLycia Bioscience raised?
CaLycia Bioscience has raised $400K in total funding. The most recent round was Pre-Seed. The last funding was announced in January 2026.
Who are CaLycia Bioscience's investors?
CaLycia Bioscience's investors include EPIC Ventures, Cumming Capital Management.
Where is CaLycia Bioscience headquartered?
CaLycia Bioscience is headquartered in Salt Lake City, United States.
What does CaLycia Bioscience do?
CaLycia Bioscience is a biotechnology startup that develops myeloid-based cell therapy for treating tumors such as glioblastoma.
What stage is CaLycia Bioscience at?
CaLycia Bioscience is at the Pre-Seed stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"CaLycia Bioscience — Funding & Investors." VCBacked, January 15, 2026, https://www.vcbacked.co/company/calycia-bioscience. Accessed July 2, 2026.
APA
VCBacked. (2026). CaLycia Bioscience — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/calycia-bioscience
Wikipedia (cite web)
{{cite web |title=CaLycia Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/calycia-bioscience |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .